AACR Annual Meeting 2023 AACR 2023: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Patients With Resectable NSCLC
Lung Cancer Closing the diagnostic gap: A three-step AI safety-net workflow to capture missed lung nodules on chest radiographs in routine clinical practice
